Provided by Tiger Trade Technology Pte. Ltd.

Outlook Therapeutics, Inc.

0.4131
-0.0215-4.95%
Post-market: 0.4116-0.0015-0.36%19:56 EST
Volume:1.13M
Turnover:480.25K
Market Cap:34.32M
PE:-0.23
High:0.4478
Open:0.4370
Low:0.4100
Close:0.4346
52wk High:3.39
52wk Low:0.3801
Shares:83.07M
Float Shares:67.73M
Volume Ratio:0.62
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7900
EPS(LYR):-1.7940
ROE:-3.65%
ROA:-209.03%
PB:-0.89
PE(LYR):-0.23

Loading ...

Outlook enters distribution agreement for sale of Lytenava in Switzerland

TIPRANKS
·
Feb 19

Outlook Therapeutics Signs Exclusive LYTENAVA Distribution Agreement With Mediconsult AG in Switzerland

Reuters
·
Feb 19

Outlook Therapeutics: Partnership Advances European Commercial Expansion Strategy, With Lytenava Expected to Launch in Switzerland in 2027

THOMSON REUTERS
·
Feb 19

Outlook Therapeutics Inc - Mediconsult to Market and Distribute Lytenava in Switzerland

THOMSON REUTERS
·
Feb 19

Outlook Therapeutics Expands European Footprint With Exclusive Commercial Distribution Agreement With Mediconsult Ag for Lytenava™ (Bevacizumab Gamma) in Switzerland

THOMSON REUTERS
·
Feb 19

Nasdaq Warns Outlook Therapeutics of Delisting Risk After Sub-$1 Share Price Streak

Reuters
·
Feb 19

BRIEF-Outlook Therapeutics Q1 EPS USD -0.38

Reuters
·
Feb 17

Outlook Therapeutics posts Q1 net income of USD -23.1 million, swinging from profit

Reuters
·
Feb 17

Outlook Therapeutics Q1 Net Income USD -23.1 Million

THOMSON REUTERS
·
Feb 17

Press Release: Outlook Therapeutics Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Feb 17

Outlook Therapeutics sumbits Type A meeting request to FDA

TIPRANKS
·
Feb 11

Outlook Therapeutics Inc: Intends to Continue to Work With FDA on a Path Forward for Resolving FDA's Request for Additional Confirmatory Evidence

THOMSON REUTERS
·
Feb 11

Outlook Therapeutics Submits Type a Meeting Request to FDA Following Complete Response Letter

THOMSON REUTERS
·
Feb 11

Outlook Therapeutics Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Jan 27

Press Release: Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development

Dow Jones
·
Jan 06

Sector Update: Health Care Stocks Mixed in Afternoon Trading

MT Newswires Live
·
Jan 03

Crude Oil Falls 1%; US Manufacturing Growth Eases In December

Benzinga
·
Jan 03

BUZZ-U.S. STOCKS ON THE MOVE-Rivian, Tesla, MGM Resorts

Reuters
·
Jan 02

Top Premarket Decliners

MT Newswires Live
·
Jan 02

BUZZ-U.S. STOCKS ON THE MOVE-Silver and gold miners, Baidu, Outlook Therapeutics

Reuters
·
Jan 02